Home   >  
GPCR/G Protein
  >  
Endothelin Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Endothelin Receptor

Chemical Structure Cat. No. Product Name CAS No.
Avosentan Chemical Structure
 BCP28417 Avosentan 290815-26-8
Avosentan is a potent, selective endothelin receptor(ETA receptor) antagonist. IC50 value: Target: ETA receptor.
Ro 46-8443 Chemical Structure
 BCP24181 Ro 46-8443 175556-12-4
Ro 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. Ro 46-8443 displays an at least 100-fold selectivity for ETB (IC50: 34-69 nM) over ETA receptors (IC50: 6800 nM).
Sparsentan Chemical Structure
 BCP23969 Sparsentan 254740-64-2
Sparsentan is a highly potent dual angiotensin II and endothelin A receptor antagonist with Kis of 0.8 and 9.3 nM, respectively.
TAK 044 Chemical Structure
 BCP37381 TAK 044 157380-72-8
TAK-044 has been found to be an endothelin receptor antagonist that was once studied against some sort of liver disorders and subarachnoid haemorrhage.
BMS-182874 Hydrochloride Chemical Structure
 BCP33050 BMS-182874 Hydrochloride 1215703-04-0
BMS 182874 hydrochloride is a potent, selective and competitive non-peptide endothelin ETA receptor antagonist (Ki = 48 nM).
BQ-788 Chemical Structure
 BCP29520 BQ-788 173326-37-9
BQ788 is a endothelin B receptor antagonist. BQ788 attenuates stab wound injury-induced reactive astrocytes in rat brain. BQ788 were well tolerated and showed signs of directly and indirectly reducing the viability of melanoma cells.
Carperitide Chemical Structure
 BCP12639 Carperitide 89213-87-6
Carperitide is a polypeptide.
Darusentan Chemical Structure
 BCP13024 Darusentan 171714-84-4
Darusentan (LU-135252; HMR-4005) is an endothelin receptor antagonist.
Hydroxy Bosentan Chemical Structure
 BCP15832 Hydroxy Bosentan 253688-60-7
Hydroxy Bosentan is a metabolite of Bosentan.
Aprocitentan Chemical Structure
 BCP28125 Aprocitentan 1103522-45-7
Aprocitentan is the major and pharmacologically active metabolite of macitentan, which is dual ETA/ETB antagonist designed for tissue targeting.
123下一页共 23 条记录 1 / 3 页 
0086-13720134139